Medical Care

Global PROTAC Drug Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for PROTAC Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PROTAC Drug.
The PROTAC Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PROTAC Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PROTAC Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arvinas
Nurix
Kymera Therapeutics
C4 Therapeutics
Ranok Therapeutics
Accutar Biotechnology
BeiGene Ltd.
Hinova Pharmaceuticals
Haisco Pharmaceutical
Segment by Type
Based on CRBN
Based on VHL
Segment by Application
Cancer
Autoimmune Diseases
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PROTAC Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PROTAC Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Based on CRBN
1.2.3 Based on VHL
1.3 Market by Application
1.3.1 Global PROTAC Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PROTAC Drug Market Perspective (2020-2031)
2.2 Global PROTAC Drug Growth Trends by Region
2.2.1 Global PROTAC Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PROTAC Drug Historic Market Size by Region (2020-2025)
2.2.3 PROTAC Drug Forecasted Market Size by Region (2026-2031)
2.3 PROTAC Drug Market Dynamics
2.3.1 PROTAC Drug Industry Trends
2.3.2 PROTAC Drug Market Drivers
2.3.3 PROTAC Drug Market Challenges
2.3.4 PROTAC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PROTAC Drug Players by Revenue
3.1.1 Global Top PROTAC Drug Players by Revenue (2020-2025)
3.1.2 Global PROTAC Drug Revenue Market Share by Players (2020-2025)
3.2 Global PROTAC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PROTAC Drug Revenue
3.4 Global PROTAC Drug Market Concentration Ratio
3.4.1 Global PROTAC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PROTAC Drug Revenue in 2024
3.5 Global Key Players of PROTAC Drug Head office and Area Served
3.6 Global Key Players of PROTAC Drug, Product and Application
3.7 Global Key Players of PROTAC Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PROTAC Drug Breakdown Data by Type
4.1 Global PROTAC Drug Historic Market Size by Type (2020-2025)
4.2 Global PROTAC Drug Forecasted Market Size by Type (2026-2031)
5 PROTAC Drug Breakdown Data by Application
5.1 Global PROTAC Drug Historic Market Size by Application (2020-2025)
5.2 Global PROTAC Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PROTAC Drug Market Size (2020-2031)
6.2 North America PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PROTAC Drug Market Size by Country (2020-2025)
6.4 North America PROTAC Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PROTAC Drug Market Size (2020-2031)
7.2 Europe PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PROTAC Drug Market Size by Country (2020-2025)
7.4 Europe PROTAC Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PROTAC Drug Market Size (2020-2031)
8.2 Asia-Pacific PROTAC Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PROTAC Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific PROTAC Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PROTAC Drug Market Size (2020-2031)
9.2 Latin America PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PROTAC Drug Market Size by Country (2020-2025)
9.4 Latin America PROTAC Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PROTAC Drug Market Size (2020-2031)
10.2 Middle East & Africa PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PROTAC Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa PROTAC Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas PROTAC Drug Introduction
11.1.4 Arvinas Revenue in PROTAC Drug Business (2020-2025)
11.1.5 Arvinas Recent Development
11.2 Nurix
11.2.1 Nurix Company Details
11.2.2 Nurix Business Overview
11.2.3 Nurix PROTAC Drug Introduction
11.2.4 Nurix Revenue in PROTAC Drug Business (2020-2025)
11.2.5 Nurix Recent Development
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Details
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics PROTAC Drug Introduction
11.3.4 Kymera Therapeutics Revenue in PROTAC Drug Business (2020-2025)
11.3.5 Kymera Therapeutics Recent Development
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Details
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics PROTAC Drug Introduction
11.4.4 C4 Therapeutics Revenue in PROTAC Drug Business (2020-2025)
11.4.5 C4 Therapeutics Recent Development
11.5 Ranok Therapeutics
11.5.1 Ranok Therapeutics Company Details
11.5.2 Ranok Therapeutics Business Overview
11.5.3 Ranok Therapeutics PROTAC Drug Introduction
11.5.4 Ranok Therapeutics Revenue in PROTAC Drug Business (2020-2025)
11.5.5 Ranok Therapeutics Recent Development
11.6 Accutar Biotechnology
11.6.1 Accutar Biotechnology Company Details
11.6.2 Accutar Biotechnology Business Overview
11.6.3 Accutar Biotechnology PROTAC Drug Introduction
11.6.4 Accutar Biotechnology Revenue in PROTAC Drug Business (2020-2025)
11.6.5 Accutar Biotechnology Recent Development
11.7 BeiGene Ltd.
11.7.1 BeiGene Ltd. Company Details
11.7.2 BeiGene Ltd. Business Overview
11.7.3 BeiGene Ltd. PROTAC Drug Introduction
11.7.4 BeiGene Ltd. Revenue in PROTAC Drug Business (2020-2025)
11.7.5 BeiGene Ltd. Recent Development
11.8 Hinova Pharmaceuticals
11.8.1 Hinova Pharmaceuticals Company Details
11.8.2 Hinova Pharmaceuticals Business Overview
11.8.3 Hinova Pharmaceuticals PROTAC Drug Introduction
11.8.4 Hinova Pharmaceuticals Revenue in PROTAC Drug Business (2020-2025)
11.8.5 Hinova Pharmaceuticals Recent Development
11.9 Haisco Pharmaceutical
11.9.1 Haisco Pharmaceutical Company Details
11.9.2 Haisco Pharmaceutical Business Overview
11.9.3 Haisco Pharmaceutical PROTAC Drug Introduction
11.9.4 Haisco Pharmaceutical Revenue in PROTAC Drug Business (2020-2025)
11.9.5 Haisco Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global PROTAC Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Based on CRBN
Table 3. Key Players of Based on VHL
Table 4. Global PROTAC Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global PROTAC Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global PROTAC Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global PROTAC Drug Market Share by Region (2020-2025)
Table 8. Global PROTAC Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global PROTAC Drug Market Share by Region (2026-2031)
Table 10. PROTAC Drug Market Trends
Table 11. PROTAC Drug Market Drivers
Table 12. PROTAC Drug Market Challenges
Table 13. PROTAC Drug Market Restraints
Table 14. Global PROTAC Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global PROTAC Drug Market Share by Players (2020-2025)
Table 16. Global Top PROTAC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PROTAC Drug as of 2024)
Table 17. Ranking of Global Top PROTAC Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by PROTAC Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of PROTAC Drug, Headquarters and Area Served
Table 20. Global Key Players of PROTAC Drug, Product and Application
Table 21. Global Key Players of PROTAC Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PROTAC Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global PROTAC Drug Revenue Market Share by Type (2020-2025)
Table 25. Global PROTAC Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global PROTAC Drug Revenue Market Share by Type (2026-2031)
Table 27. Global PROTAC Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global PROTAC Drug Revenue Market Share by Application (2020-2025)
Table 29. Global PROTAC Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global PROTAC Drug Revenue Market Share by Application (2026-2031)
Table 31. North America PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific PROTAC Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific PROTAC Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific PROTAC Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Arvinas Company Details
Table 47. Arvinas Business Overview
Table 48. Arvinas PROTAC Drug Product
Table 49. Arvinas Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 50. Arvinas Recent Development
Table 51. Nurix Company Details
Table 52. Nurix Business Overview
Table 53. Nurix PROTAC Drug Product
Table 54. Nurix Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 55. Nurix Recent Development
Table 56. Kymera Therapeutics Company Details
Table 57. Kymera Therapeutics Business Overview
Table 58. Kymera Therapeutics PROTAC Drug Product
Table 59. Kymera Therapeutics Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 60. Kymera Therapeutics Recent Development
Table 61. C4 Therapeutics Company Details
Table 62. C4 Therapeutics Business Overview
Table 63. C4 Therapeutics PROTAC Drug Product
Table 64. C4 Therapeutics Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 65. C4 Therapeutics Recent Development
Table 66. Ranok Therapeutics Company Details
Table 67. Ranok Therapeutics Business Overview
Table 68. Ranok Therapeutics PROTAC Drug Product
Table 69. Ranok Therapeutics Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 70. Ranok Therapeutics Recent Development
Table 71. Accutar Biotechnology Company Details
Table 72. Accutar Biotechnology Business Overview
Table 73. Accutar Biotechnology PROTAC Drug Product
Table 74. Accutar Biotechnology Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 75. Accutar Biotechnology Recent Development
Table 76. BeiGene Ltd. Company Details
Table 77. BeiGene Ltd. Business Overview
Table 78. BeiGene Ltd. PROTAC Drug Product
Table 79. BeiGene Ltd. Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 80. BeiGene Ltd. Recent Development
Table 81. Hinova Pharmaceuticals Company Details
Table 82. Hinova Pharmaceuticals Business Overview
Table 83. Hinova Pharmaceuticals PROTAC Drug Product
Table 84. Hinova Pharmaceuticals Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 85. Hinova Pharmaceuticals Recent Development
Table 86. Haisco Pharmaceutical Company Details
Table 87. Haisco Pharmaceutical Business Overview
Table 88. Haisco Pharmaceutical PROTAC Drug Product
Table 89. Haisco Pharmaceutical Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
Table 90. Haisco Pharmaceutical Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report


List of Figures
Figure 1. PROTAC Drug Picture
Figure 2. Global PROTAC Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PROTAC Drug Market Share by Type: 2024 VS 2031
Figure 4. Based on CRBN Features
Figure 5. Based on VHL Features
Figure 6. Global PROTAC Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global PROTAC Drug Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Autoimmune Diseases Case Studies
Figure 10. Other Case Studies
Figure 11. PROTAC Drug Report Years Considered
Figure 12. Global PROTAC Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global PROTAC Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global PROTAC Drug Market Share by Region: 2024 VS 2031
Figure 15. Global PROTAC Drug Market Share by Players in 2024
Figure 16. Global Top PROTAC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PROTAC Drug as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by PROTAC Drug Revenue in 2024
Figure 18. North America PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America PROTAC Drug Market Share by Country (2020-2031)
Figure 20. United States PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe PROTAC Drug Market Share by Country (2020-2031)
Figure 24. Germany PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific PROTAC Drug Market Share by Region (2020-2031)
Figure 32. China PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America PROTAC Drug Market Share by Country (2020-2031)
Figure 40. Mexico PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa PROTAC Drug Market Share by Country (2020-2031)
Figure 44. Turkey PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Arvinas Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 48. Nurix Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 49. Kymera Therapeutics Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 50. C4 Therapeutics Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 51. Ranok Therapeutics Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 52. Accutar Biotechnology Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 53. BeiGene Ltd. Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 54. Hinova Pharmaceuticals Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 55. Haisco Pharmaceutical Revenue Growth Rate in PROTAC Drug Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies